Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease-Reference-Cited by-同舟云学术

Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease

Published:2017-04 Issue: Volume:55 Page:58-64
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Annereau M.,Willekens C.,El Halabi L.,Chahine C.,Saada V.,Auger N.,Danu A.,Bermudez E.,Lazarovici J.,Ghez D.,Leary A.,Pistilli B.,Lemare F.,Solary E.,de Botton S.,Desmaris R.-P.,Micol J.-B.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference25 articles.

1. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

2. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol.,2009

3. Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

4. Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study;Kornblith;J. Clin. Oncol.,2002

5. Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia;Pedersen-Bjergaard;Hematol. Am. Soc. Hematol. Educ. Program,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy-related myelodysplastic syndromes in the genomics era;Bulletin du Cancer;2023-11

2. Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature;Frontiers in Immunology;2023-01-13

3. DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28

4. Diagnosis and treatment of therapy-related acute myeloid leukemia;Critical Reviews in Oncology/Hematology;2022-03

5. The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance;Current Cancer Drug Targets;2021-05-27